4//SEC Filing
BIOPHAN TECHNOLOGIES INC 4
Accession 0001144204-07-049818
CIK 0001084000operating
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 6:02 PM ET
Size
18.0 KB
Accession
0001144204-07-049818
Insider Transaction Report
Form 4
WEINER MICHAEL L
DirectorCEO, President
Transactions
- Conversion
Convertible Promissory Note
2007-07-19$0.67/sh−3,546,118$2,375,899→ 2,611,940 total(indirect: see footnote)Exercise: $0.67Exp: 2011-01-23→ Common Stock (3,546,118 underlying) - Conversion
Common Stock
2007-07-19$0.67/sh+3,546,118$2,375,899→ 3,546,118 total(indirect: see footnote) - Award
Employee Stock Options
2007-07-27+1,000,000→ 2,800,000 totalExercise: $0.28From: 2007-07-27Exp: 2017-07-27→ Common Stock (1,000,000 underlying)
Holdings
- 207,361
Common Stock
- 4,923,080(indirect: see footnote)
Common Stock
- 300,644(indirect: see footnote)
Common Stock
- 500,000(indirect: see footnote)
Stock Purchase Warrants
Exercise: $2.49Exp: 2008-05-26→ Common Stock (500,000 underlying) - 1,198,630(indirect: see footnote)
Stock Purchase Warrants
Exercise: $0.67Exp: 2011-01-23→ Common Stock (1,198,630 underlying) - 656,756(indirect: see footnote)
Common Stock
- 228,310(indirect: see footnote)
Convertible Promissory Note
Exercise: $2.19→ Common Stock (228,310 underlying)
Footnotes (7)
- [F1]On July19, 2007, Biomed converted $2,180,000 of Convertible Promissory Notes into 3,253,731 shares of Biophan common stock at a conversion price of $0.67. In addition, accrued interest of $195,899 was converted into 292,387 shares.
- [F2]Held held by Biomed Solutions, LLC ("Biomed"), of which the reporting person is the Manager. Biomed is 57% owned by Technology Innovations, LLC ("TI"), of which the reporting person is a member and the Manager. The reporting person disclaims beneficial ownership of the issuer's securities held by Biomed except to the extent of his indirect ownership interest in Biomed through TI.
- [F3]Held by TI. The reporting person disclaims beneficial ownership of the issuer's securities held by TI except to the extent of his ownership interest in TI.
- [F4]Held by Myotech, LLC ("Myotech"), of which the reporting person is a director. The reporting person disclaims beneficial ownership of the issuer's securities held by Myotech except to the extent of his pecuniary interest in Myotech.
- [F5]The reporting person holds various options to purchase common stock granted under the Issuer's employee stock option plans. The options are exercisable at prices ranging from $0.18 to $0.97 per share and expire on various dates ranging from 1/1/11 to 7/27/17.
- [F6]Convertible or exercisible at option of holder.
- [F7]Payable on demand.
Documents
Issuer
BIOPHAN TECHNOLOGIES INC
CIK 0001084000
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001084000
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 6:02 PM ET
- Size
- 18.0 KB